146 related articles for article (PubMed ID: 35436678)
1. Rapid FISH results within one hour.
Wren C; Tegg E
Cancer Genet; 2022 Jun; 264-265():66-70. PubMed ID: 35436678
[TBL] [Abstract][Full Text] [Related]
2. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Tansatit M
Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
[TBL] [Abstract][Full Text] [Related]
3. FISH panels for hematologic malignancies.
Sreekantaiah C
Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
[TBL] [Abstract][Full Text] [Related]
4. The impact of the new fish technologies on the cytogenetics of haematological malignancies.
Kearney L
Br J Haematol; 1999 Mar; 104(4):648-58. PubMed ID: 10192422
[No Abstract] [Full Text] [Related]
5. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
6. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
[TBL] [Abstract][Full Text] [Related]
7. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic application of FISH to hematological malignancies.
Najfeld V
Cancer Invest; 2003; 21(5):807-14. PubMed ID: 14628438
[No Abstract] [Full Text] [Related]
9. Split-signal FISH for detection of chromosome aberrations.
van Dongen JJ; van der Burg M; Langerak AW
Hematology; 2005; 10 Suppl 1():66-72. PubMed ID: 16188640
[TBL] [Abstract][Full Text] [Related]
10. Multicolor FISH.
Jalal SM; Law ME
Methods Mol Biol; 2002; 204():105-20. PubMed ID: 12397793
[No Abstract] [Full Text] [Related]
11. Miniaturized FISH for screening of onco-hematological malignancies.
Zanardi A; Bandiera D; Bertolini F; Corsini CA; Gregato G; Milani P; Barborini E; Carbone R
Biotechniques; 2010 Jul; 49(1):497-504. PubMed ID: 20615202
[TBL] [Abstract][Full Text] [Related]
12. [Chromosomal analysis, fluorescence in situ hybridization method, and spectral karyotyping in hematologic malignancies].
Nara N
Rinsho Byori; 2003 Jun; Suppl 126():124-30. PubMed ID: 12905952
[No Abstract] [Full Text] [Related]
13. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
[TBL] [Abstract][Full Text] [Related]
14. [Application of new FISH techniques for cytogenetic analysis in hematological malignancies].
Kakazu N; Abe T
Rinsho Ketsueki; 2002 May; 43(5):316-8. PubMed ID: 12096476
[No Abstract] [Full Text] [Related]
15. Oligo-based High-resolution aCGH Analysis Enhances Routine Cytogenetic Diagnostics in Haematological Malignancies.
Kjeldsen E
Cancer Genomics Proteomics; 2015; 12(6):301-37. PubMed ID: 26543079
[TBL] [Abstract][Full Text] [Related]
16. [Fluorescence in-situ hybridization (FISH). Method and application].
Fischer K; Bentz M; Döhner H
Med Klin (Munich); 1997 May; 92(5):279-83. PubMed ID: 9244834
[No Abstract] [Full Text] [Related]
17. Multicolor fluorescence in situ hybridization characterization of cytogenetically polyclonal hematologic malignancies.
Davidsson J; Paulsson K; Johansson B
Cancer Genet Cytogenet; 2005 Dec; 163(2):180-3. PubMed ID: 16337865
[TBL] [Abstract][Full Text] [Related]
18. Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis.
Knight SJ; Flint J
J Med Genet; 2000 Jun; 37(6):401-9. PubMed ID: 10851249
[TBL] [Abstract][Full Text] [Related]
19. Discrepant Cytogenetic and Interphase Fluorescence In Situ Hybridization (I-FISH) Results from Bone Marrow Specimens of Patients with Hematologic Neoplasms.
Cantú ES; Dong H; Forsyth DR; Espinoza FP; Papenhausen PR
Ann Clin Lab Sci; 2018 May; 48(3):264-272. PubMed ID: 29970427
[TBL] [Abstract][Full Text] [Related]
20. A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies.
Hiemenz MC; Oberley MJ; Doan A; Aye L; Ji J; Schmidt RJ; Biegel JA; Bhojwani D; Raca G
Cancer Genet; 2021 Jun; 254-255():25-33. PubMed ID: 33571894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]